A fragment of the DNA basic region (br) of the GCN4 bZIP transcription factor has been modified to include two His residues at designed i and i+4 positions of its N-terminus. The resulting monomeric peptide (brHis2) does not bind to its consensus target DNA site (5'-GTCAT-3'). However, addition of Pd(en)Cl2 (en, ethylenediamine) promotes a high-affinity interaction with exquisite selectivity for this sequence. The peptide-DNA complex is disassembled by addition of a slight excess of a palladium chelator, and the interaction can be reversibly switched multiple times by playing with controlled amounts of either the metal complex or the chelator. Importantly, while the peptide brHis2 fails to translocate across cell membranes on its own, addition of the palladium reagent induces an efficient cell internalization of this peptide. In short, we report (1) a designed, short peptide that displays highly selective, major groove DNA binding, (2) a reversible, metal-dependent DNA interaction, and (3) a metal-promoted cell internalization of this basic peptide.
A fragment of the DNA basic region (br) of the GCN4 bZIP transcription factor has been modified to include two His residues at designed i and i+4 positions of its N-terminus. The resulting monomeric peptide (brHis2) does not bind to its consensus target DNA site (5'-GTCAT-3'). However, addition of Pd(en)Cl2 (en, ethylenediamine) promotes a high-affinity interaction with exquisite selectivity for this sequence. The peptide-DNA complex is disassembled by addition of a slight excess of a palladium chelator, and the interaction can be reversibly switched multiple times by playing with controlled amounts of either the metal complex or the chelator. Importantly, while the peptide brHis2 fails to translocate across cell membranes on its own, addition of the palladium reagent induces an efficient cell internalization of this peptide. In short, we report (1) a designed, short peptide that displays highly selective, major groove DNA binding, (2) a reversible, metal-dependent DNA interaction, and (3) a metal-promoted cell internalization of this basic peptide.
Protein expression
depends on the concerted action of transcription
factors (TFs), which are specialized proteins that specifically bind
to regulatory DNA sequences, thereby modulating the transcription
of downstream genes.[1] Over the past few
years, there has been a great interest in the development of miniaturized
models of TFs capable of reproducing their DNA-binding properties,
as they might open interesting biomedical opportunities.[2] These peptides interact with the DNA mainly through
the major groove and, thus, might provide a compelling alternative
to classic DNA binding agents that interact by intercalation or by
insertion into the minor groove.[3] However,
the design and preparation of this type of minimalistic peptides has
proven extremely challenging.[2,4]The most successful
examples have been inspired by the DNA binding
domain of bZIP proteins such as GCN4, an archetypal member of this
family of TFs that specifically binds to palindromic ATF/CREB (5′-ATGAC-GTCAT-3′)
or AP1 (5′-ATGA(c)TCAT-3′) sites as a leucine zipper-mediated
dimer of uninterrupted α-helices.[5] The DNA interaction occurs through the N-terminal basic region (br),
which folds into an α-helix upon insertion in the major groove
of the target DNA site.[6]Following
the seminal work by Kim and co-workers in 1990,[7] a number of groups have demonstrated that the
complete leucine zipper of the GCN4 DNA binding domain could be replaced
by artificial dimerizing elements without significantly compromising
the DNA recognition properties of the system.[8] In contrast, monomeric GCN4 peptides display very low DNA binding
affinity,[9] probably because the high entropic
cost associated with the folding of the peptide chain into the α-helical
conformation, required for DNA binding, is not compensated by the
enthalpic gain of a monomeric interaction.[10,11] A couple of reports have shown that introducing lactam bridges or
covalent staples can promote DNA binding, although the affinity and
selectivity of these modified systems are rather modest.[12] Better results have been obtained by grafting
key DNA binding residues from the bZIP basic regions into stable peptide
scaffolds that support the α-helical conformation.[13] In an alternative approach, our group has demonstrated
that tethering the peptides to prosthetic minor groove binders that
establish accessory stabilizing interactions can also lead to stable
DNA complexes.[14] Furthermore, we have shown
that such tethering can also be achieved through a nickel-mediated
coordination with bisbenzamidine–bipyridine conjugates.[15] Tethering metal-based intercalators to peptides
has also allowed cooperative binding to DNA.[16] Despite these important advances, an efficient and selective major
groove DNA interaction by simple, minimalist peptides, featuring natural
amino acids, has not been demonstrated.Herein we show that
a designed bis-histidine grafted peptide featuring
23 amino acids of the basic region of GCN4 binds its consensus DNA
site (5′-GTCAT-3′) with high affinity and specificity
when treated with a slight excess of [Pd(en)Cl2. The palladium
complex works as a stapling agent that favors the required α-helical
folding and, ultimately, the insertion of the peptide into the major
groove of the target DNA (Figure ). Noticeably, the interaction can be reversibly switched
by controlling the relative amounts of the palladium complex and a
metal sequestering agent. Overall, we report the shortest, high-affinity,
sequence-selective DNA binding natural peptide described so far, the
first on–off, cyclically switchable peptide DNA binder, and
the use of a palladium complex to control a selective DNA interaction.
Figure 1
Top: Schematic
structure of the supramolecular assembly into specific
DNA sites of a modified GCN4 basic region featuring two His residues
(His230 and His234, brHis) in the presence of a metal clip. Bottom: Sequences
of the natural GCN4 basic region and the mutated peptides brHis and brHis. Mutated residues
are in bold.
Top: Schematic
structure of the supramolecular assembly into specific
DNA sites of a modified GCN4 basic region featuring two His residues
(His230 and His234, brHis) in the presence of a metal clip. Bottom: Sequences
of the natural GCN4 basic region and the mutated peptides brHis and brHis. Mutated residues
are in bold.Importantly, we have
also found that the palladium clip triggers
the cellular uptake of otherwise nonpenetrating peptides. To the best
of our knowledge, this represents the first demonstration of a metal-promoted
cell internalization process.
Results and Discussion
Design and Synthesis
As reference for our design we
used a fragment of the GCN4 basic region comprising residues Asp226 to Arg249.[5,17] Inspection of the X-ray
structure of the GCN4/DNA complex revealed that residues Leu230 and Arg234 are oriented toward the solvent on the outer
face of the α-helix, and their substitution by His residues
should not affect the DNA contacting surface of the peptide.[3a,18] Thus, we synthesized the peptide brHis, featuring two His residues, as well as the natural basic
region peptide (br) and the control peptide brHis, in which only one residue is replaced by His (Arg234 → His).
DNA Binding of the Peptide brHis
The DNA binding properties were
studied by electrophoretic
mobility assays (EMSA) in polyacrylamide gel under nondenaturing conditions,
using SybrGold as the DNA stain.[19] As expected,
incubation of the peptide brHis with the double-stranded (ds) oligonucleotide containing the consensus binding site (5′-GTCAT-3′)
does not induce the formation of retarded bands (Figure a, lane 2), even when using
a large excess of the peptide. This is in consonance with the poor
DNA affinity of such monomeric basic regions. However, addition of
20 equiv of Pd(en)Cl2 (en, ethylenediamine) to this mixture
gives rise to a neat, new (more retarded) band that is consistent
with the formation of the desired peptide–DNA complex /[(brHis)Pd(en)]2+ (Figure a, lane 3).
Figure 2
DNA binding properties of brHis. (a) Incubation with the target ds-oligonucleotide and switching the DNA binding by addition
of DEDTC. (b) Incubation with mutated dsDNA . Concentration of the components when present: 75 nM dsDNA,
2 μM brHis, 20 μM
Pd(en)Cl2. (a) Lane 1: dsDNA; lane 2: dsDNA and brHis; lane 3: previous mixture and Pd(en)Cl2; lane 4: mixture in lane 3 after addition of 50 equiv of
DEDTC; lane 5: addition of 60 equiv of Pd(en)Cl2 to the
mixture in lane 4; lane 6: mixture in lane 5 after addition of 150
equiv of DEDTC; lane 7: addition of 200 equiv of Pd(en)Cl2 to the mixture in lane 6. All the equiv are expressed relative to brHis. Samples were resolved on a
10% nondenaturing polyacrylamide gel and 0.5× TBE buffer over
40 min at 25 °C and stained with SyBrGold (5 μL in 50 mL
of 1× TBE) for 10 min, followed by fluorescence visualization.
Oligonucleotide sequences (only one strand shown, brHis binding site in bold): : 5′-CGC GTCAT AATTGAGAG CGC-3′; : 5′-CGC GTAT AATTGAGAG
CGC-3′.
DNA binding properties of brHis. (a) Incubation with the target ds-oligonucleotide and switching the DNA binding by addition
of DEDTC. (b) Incubation with mutated dsDNA . Concentration of the components when present: 75 nM dsDNA,
2 μM brHis, 20 μM
Pd(en)Cl2. (a) Lane 1: dsDNA; lane 2: dsDNA and brHis; lane 3: previous mixture and Pd(en)Cl2; lane 4: mixture in lane 3 after addition of 50 equiv of
DEDTC; lane 5: addition of 60 equiv of Pd(en)Cl2 to the
mixture in lane 4; lane 6: mixture in lane 5 after addition of 150
equiv of DEDTC; lane 7: addition of 200 equiv of Pd(en)Cl2 to the mixture in lane 6. All the equiv are expressed relative to brHis. Samples were resolved on a
10% nondenaturing polyacrylamide gel and 0.5× TBE buffer over
40 min at 25 °C and stained with SyBrGold (5 μL in 50 mL
of 1× TBE) for 10 min, followed by fluorescence visualization.
Oligonucleotide sequences (only one strand shown, brHis binding site in bold): : 5′-CGC GTCAT AATTGAGAG CGC-3′; : 5′-CGC GTAT AATTGAGAG
CGC-3′.Importantly, the complex
can be dismantled by the addition of a
small excess of an external Pd chelator (diethyldithiocarbamate, DEDTC, Figure a, lane 4), a result
that supports the role of the palladium reagent in promoting the DNA
binding. Furthermore, the DNA complex can be reversibly assembled
or dismantled by controlling the relative amounts of the Pd complex
and the DEDTC (Figure a, lanes 4–7). To our knowledge, reversible cyclic DNA binding
of such minimalist synthetic peptides lacks any precedent.[20,21]The metal-promoted interaction is highly selective; therefore,
mutation in a single position of the target site was enough to completely
abolish the DNA binding (Figure b and Figure S11). It is
also important to note that neither the natural GCN4 basic region
(br) nor the peptide containing a single His mutation
(brHis) gives rise to new bands in the presence of palladium
(Figure S11), which confirms the requirement
of the two coordinating histidines.The above data are consistent
with the proposed DNA binding by
a peptide monomer. Binding by a dimeric species is unlikely, as it
would require a specific arrangement of two basic regions that are
difficult to envision. Nevertheless, to fully discard the presence
of such dimeric species binding to the DNA target, we carried out
control experiments with a disulfide dimer of the basic region peptide
[br(SS)], similar
to that used by Kim et al.[17a] As shown
in Figure , the interaction
of this dipeptide with a DNA featuring either its consensus dimeric
target site () or the monomeric
half site () leads to slower migrating
bands than those observed for the DNA complex with [(brHis)Pd(en)]2+. The retarded band
observed in lane 8 with , in the
presence of brHis and the Pd
reagent, is consistent with the insertion of two monomeric peptides
in their respective half-sites. ESI/MS analysis of the peptide-Pd(en)2 complexes (Figure S19) and UV/vis
experiments with Pd(bipy)Cl2 in the presence of the target
DNA (Figure S17) also support the formation
of DNA complexes with monomeric peptides (see the Supporting Information).
Figure 3
Comparative EMSA experiment with monomeric brHis and br(SS). Lanes 1–4: 75 nM ; lanes 2, 3: 2 μM brHis; lane 3: 20 μM Pd(en)Cl2; lane 4: 1.2 μM br(SS); lanes 5–8:
75 nM ; lane 6: 1.2 μM br(SS); lanes 7, 8:
2 μM brHis; lane 8: 20
μM Pd(en)Cl2. The dsDNA features two binding sites in neighbor sequences. We have
used this ds-oligonucleotide: 5′-TGGAG ATGA cg TCAT CTCGT-3′ (only one strand shown). Each peptide of the disulfide br(SS) features the
sequence of peptide br (Figure ), with the C-terminal Arg (249) substituted
by Gly-Gly-Cys.
Comparative EMSA experiment with monomeric brHis and br(SS). Lanes 1–4: 75 nM ; lanes 2, 3: 2 μM brHis; lane 3: 20 μM Pd(en)Cl2; lane 4: 1.2 μM br(SS); lanes 5–8:
75 nM ; lane 6: 1.2 μM br(SS); lanes 7, 8:
2 μM brHis; lane 8: 20
μM Pd(en)Cl2. The dsDNA features two binding sites in neighbor sequences. We have
used this ds-oligonucleotide: 5′-TGGAG ATGA cg TCAT CTCGT-3′ (only one strand shown). Each peptide of the disulfide br(SS) features the
sequence of peptide br (Figure ), with the C-terminal Arg (249) substituted
by Gly-Gly-Cys.
DNA Binding Is Only Observed
in the Presence of Specific Metal
Complexes
At this point we checked whether other metal ions
could also promote DNA binding, or if the induction of the DNA interaction
was exclusive for the palladium reagent. As shown in Figure a, mixing the target dsDNA with brHis in the presence of several Ni2+, Zn2+, Cu2+, Co2+, or Fe2+ salts failed
to give rise to new bands in the EMSA (Figure a, lanes 4–8). It is important to
highlight the failure of NiCl2, as this metal complex had
been successfully used for promoting bivalent major–minor groove
interactions in cooperation with bisbenzamidine–bipyridine
conjugates.[15] However, it is not useful
in the case of the more challenging monovalent peptide–DNA
interactions.
Figure 4
DNA properties of brHis with
different metal salts. Lane 1: 75 nM ; all other lanes: 75 nM , 2 μM brHis, 20 μM metal complexes
(same conditions as in Figure a and b). Note: The gold dichloride complexes present a positive
charge.
DNA properties of brHis with
different metal salts. Lane 1: 75 nM ; all other lanes: 75 nM , 2 μM brHis, 20 μM metal complexes
(same conditions as in Figure a and b). Note: The gold dichloride complexes present a positive
charge.Not surprisingly, trans-[Pd(PPh3)2Cl2] also failed to induce
DNA binding, while Pd(bipy)Cl2 was roughly as effective
as Pd(en)Cl2 (Figure S12). We
also proved that an analogous
complex featuring nitrate instead of chloride ligands Pd(bipy)(NO3)2 is also a very efficient binding trigger (Figure S12). Therefore, it appears that square
planar cis-Pd(II) complexes present the ideal coordination
properties to promote an effective folding, and interaction to the
target DNA.[22] Notably, similar PtCl2 complexes were ineffective, most probably because of the
low reactivity and kinetic stability of the precursor salts (Figure b). However, electrophilic
Au(III) complexes, particularly [Au(bipy)Cl2]+, which exhibit a square planar geometry similar to that of Pd(II),
can also promote the DNA binding (Figure c). This result is quite appealing as, to
the best of our knowledge, gold complexes had never been used in related
bio-supramolecular strategies.
Spectroscopic Characterization
of the Palladium-Promoted Interaction
between brHis and the DNA
In order to obtain more information on the DNA binding process,
we performed fluorescence anisotropy titrations by adding brHis to a solution containing 20 μM cis-[Pd(en)Cl2] and a tetramethylrhodamine (TMR)-labeled
ds-oligonucleotide containing the target sequence. The addition of brHis led to a progressive increase
in the fluorescence anisotropy of the TMR label. The data could be
fitted to a simplified 1:1 binding model by formally considering the
complex [(brHis)(Pd(en))]2+ as a single DNA binding unit, with an apparent KD ≈ 24 ± 17 nM (Figure , left).
Figure 5
Left: Representative fluorescence anisotropy
titration of a 25
nM solution of the TMR-labeled target ds-oligonucleotide (TMR-5′-CGCGTCATAATTGAGAGCGC-3′, only one strand shown) in the presence
of 20 μM Pd(en)Cl2 and increasing concentrations
of brHis. The best fit to a
1:1 binding model is also shown. Measurements were made in 20 mM Tris-HCl
buffer pH 7.5 and 100 mM NaCl. Right: CD of a 5 μM solution
of brHis (dotted line), after
the subsequent addition of 1 equiv of the target dsDNA (dashed line),
of the same solution after the addition of cis-Pd(en)Cl2 (thick solid line), and after addition of DEDTC demonstrating
the reversibility (narrow solid line). All experiments were carried
out at 25 °C, in 10 mM phosphate buffer pH 7.5 and 100 mM of
NaCl. The contribution of DNA to the CD spectrum has been subtracted
for clarity. Mean residue molar ellipticity (MRE) was calculated with
respect to the 24-mer brHis.
Left: Representative fluorescence anisotropy
titration of a 25
nM solution of the TMR-labeled target ds-oligonucleotide (TMR-5′-CGCGTCATAATTGAGAGCGC-3′, only one strand shown) in the presence
of 20 μM Pd(en)Cl2 and increasing concentrations
of brHis. The best fit to a
1:1 binding model is also shown. Measurements were made in 20 mM Tris-HCl
buffer pH 7.5 and 100 mM NaCl. Right: CD of a 5 μM solution
of brHis (dotted line), after
the subsequent addition of 1 equiv of the target dsDNA (dashed line),
of the same solution after the addition of cis-Pd(en)Cl2 (thick solid line), and after addition of DEDTC demonstrating
the reversibility (narrow solid line). All experiments were carried
out at 25 °C, in 10 mM phosphate buffer pH 7.5 and 100 mM of
NaCl. The contribution of DNA to the CD spectrum has been subtracted
for clarity. Mean residue molar ellipticity (MRE) was calculated with
respect to the 24-mer brHis.As expected for a poorly structured
peptide, the circular dichroism
(CD) spectrum of brHis presents
a relatively weak negative signal at 222 nm, even in the presence
of the consensus DNA (Figure right). Addition
of Pd(en)Cl2 to the mixture promoted a significant increase
in the negative ellipticity at 222 nm, which is consistent with the
folding of the peptide into an α-helix (Figure right, thick solid line).[23] In accordance with the results obtained by EMSA, addition
of DEDTC to the mixture resulted in a drastic decrease in the helicity
of the peptide (Figure right, narrow solid line), which correlates with the disruption
of the DNA complex. Not surprisingly, NiCl2 or Pt(en)Cl2 complexes did not promote the peptide α-helical folding
in the presence of the target DNA (Figure S14). Interestingly, adding Pd(en)Cl2 to brHis, in the absence of the target DNA, gives
rise only to a relatively small increase in helicity (Figure S15). This result raised the question
of whether the palladium is coordinating the peptide in the absence
of the DNA template. UV–vis spectra and HPLC-MS analysis of
the mixture of the peptide and the palladium complex were fully consistent
with the formation of the expected metal-clipped peptide (Figures S17 and S19). Furthermore, fluorescence
anisotropy experiments carried out by adding Pd(en)Cl2 to
a solution of a TMR-labeled brHis resulted in a progressive decrease in the anisotropy of the TMR
fluorophore at 559 nm, which agrees with the peptide acquiring a more
compact conformation (Figure S13).The above data indicate that the Pd(II) complex does coordinate
the histidine residues, but the peptide only acquires a high proportion
of helicity after addition of the target DNA. The palladium clip is
not inducing a permanent helical conformation as traditional helix
staples,[10,24] but rather it enhances the local helical
propensity, which thus facilitates the subsequent folding in the presence
of the DNA.[25,10,24] Therefore, the system maintains the folding-upon-binding behavior
of the parent GCN4 transcription factor, which might be the reason
that the [(brHis)Pd(en)]2+ complex shows such an excellent DNA selectivity.[26]
Internalization Studies: brHis Only Translocates in the Presence of Pd(II)
A key
factor when considering potential biological applications of this
type of peptides has to do with their ability to cross cell membranes.
It is known that basic peptides derived from transcription factors,
such as the Antennapedia, can be efficiently internalized.[27] Moreover, previous studies with covalently stapled
peptides suggest that the conformational restriction associated with
the stapling favors the cell uptake,[12,28] and therefore
we were curious to know if the palladium clipping might also influence
the cell penetration ability of brHis.Incubation of mammalian Vero or HeLa cells with TMR-brHis and 2-fold washing with phosphate-buffered
saline (PBS) revealed that despite the basic character of the peptide,
it shows a rather poor internalization.[29] Gratifyingly, and also quite surprisingly, addition of 1 equiv of
Pd(en)Cl2 led to the appearance of bright intracellular
emission, which was mainly localized in endosomes (Figures , S21, and S22).[30] Importantly, neither
the TMR-labeled basic region peptide (TMR-br) nor the
single mutated basic region (TMR-brHis) showed appreciable
cell translocations upon incubation using similar conditions (Figure S23).
Figure 6
Fluorescence micrographies of HeLa cells.
Bright-field images are
superimposed to the red emission channel after incubation with 5 μM TMR-brHis for 30 min at 37 °C
(left) and the same experiment in the presence of 5 μM Pd(en)Cl2 (right). The complex was preincubated (1:1) in water for
10 min before the addition. The cells were washed twice with PBS before
being observed in a fluorescence microscope. All incubations were
made in Dulbecco’s modified Eagle medium completed with 10%
fetal bovine serum. TMR: tetramethylrhodamine.
Fluorescence micrographies of HeLa cells.
Bright-field images are
superimposed to the red emission channel after incubation with 5 μM TMR-brHis for 30 min at 37 °C
(left) and the same experiment in the presence of 5 μM Pd(en)Cl2 (right). The complex was preincubated (1:1) in water for
10 min before the addition. The cells were washed twice with PBS before
being observed in a fluorescence microscope. All incubations were
made in Dulbecco’s modified Eagle medium completed with 10%
fetal bovine serum. TMR: tetramethylrhodamine.While obtaining exact information on the molecular mechanism
of
the cell internalization process will require a detailed study, we
have carried out preliminary experiments with modified peptides that
shed light on the structural requirements of the peptide for an effective
metal-switched uptake. Thus, we found that the positively charged
TMR fluorophore is not required for the metal-induced internalization,
so that when this fluorophore was replaced by the anionic fluorescein
(Figure S35, FITC-brHis), the resulting peptide replicates the palladium-induced
internalization displayed by the parent TMR-brHis. Similarly, the metal switch is perfectly operative
in specifically modified peptides, such as the double mutant peptides
Leu247 → Ala, Gln248 → Ala or
Thr236 → Ala, Ala238 → Thr, as
well as the single mutant Ala238 → Thr. Importantly,
the cell entrance of longer peptides that include amino acid insertions,
such as one containing a Leu-Ser fragment between Ala229 and His230, can be also regulated by the Pd(II) reagent.
Not surprisingly, the cell uptake is sensitive to the presence of
arginine residues, which is in consonance with the well-known role
of these amino acids in cell-penetrating peptides.[31] Thus, the double mutant Arg245 → Ser;
Arg249 → Ala peptide failed to translocate across
the plasmatic membrane, even in the presence of the palladium clip
(Figures , S33, and S34).
Figure 7
Sequences of modified peptides tested
in the metal-switched cell
uptake process, highlighting the mutated residues (blue) and whether
the peptide is internalized (green dot) or does not show an observable
translocation under the same conditions (red dot).
Sequences of modified peptides tested
in the metal-switched cell
uptake process, highlighting the mutated residues (blue) and whether
the peptide is internalized (green dot) or does not show an observable
translocation under the same conditions (red dot).Although unraveling the exact structural requirements
for the cell
uptake switch requires further work, these early results indicate
that the internalization requires the metal clip and the presence
of several arginine residues in the sequence, but is highly tolerant
to other changes. The underlying internalization mechanism is also
unknown, but it is likely that the clipping effect of the palladium
promotes a change in the amphiphilicity of the system, which favors
the membrane crossing. Our peptides will require further engineering
to promote endosomal escape; however the above results represent the
first examples of a metal-triggered cell internalization of designed
basic peptides and should foster further research in this area.[32]
Conclusion
In summary, we have introduced
a new approach for achieving a highly
selective recognition of dsDNA with a minimal (23 amino acids long),
synthetic peptide that is entirely made of natural residues. Key for
the success of the approach is the introduction of histidines in suitable i, i+4 positions in the sequence and the
addition of square-planar, Pd(II) or Au(III) reagents. In contrast
with other covalently stapled α-helical peptides, our palladium–peptide
complex is mostly unstructured in solution and acquires a predominantly
helical conformation only in the presence of the target DNA sequence.
The kinetic lability of the metal coordination facilitates the disassembly
of the supramolecular structure upon addition of external agents that
sequester the palladium.Importantly, the DNA binding and disassembly
processes can be repeated
several times, therefore providing for a fully reversible switchable
system. Also importantly, we show that while the apo-peptide presents
a very poor cellular uptake, the addition of the palladium reagent
triggers an efficient internalization. This is the first demonstration
of triggering the cell penetration of a short, basic peptide using
a metal complex; this tactic promises to find further applications
in dynamic cellular delivery.
Authors: Federico Bernal; Andrew F Tyler; Stanley J Korsmeyer; Loren D Walensky; Gregory L Verdine Journal: J Am Chem Soc Date: 2007-02-07 Impact factor: 15.419
Authors: Jinbo Zhu; Cally J E Haynes; Marion Kieffer; Jake L Greenfield; Ryan D Greenhalgh; Jonathan R Nitschke; Ulrich F Keyser Journal: J Am Chem Soc Date: 2019-07-11 Impact factor: 15.419